BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28237123)

  • 1. Temporal Trends in Intravenous Thrombolysis in Acute Ischemic Stroke: Experience from a Tertiary Care Center in India.
    Khurana D; Das B; Kumar A; Kumar S A; Khandelwal N; Lal V; Prabhakar S
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1266-1273. PubMed ID: 28237123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cluster-Randomized Trial of Thrombolysis Implementation Support in Metropolitan and Regional Australian Stroke Centers: Lessons for Individual and Systems Behavior Change.
    Levi CR; Attia JA; D'Este C; Ryan AE; Henskens F; Kerr E; Parsons MW; Sanson-Fisher RW; Bladin CF; Lindley RI; Middleton S; Paul CL; ;
    J Am Heart Assoc; 2020 Feb; 9(3):e012732. PubMed ID: 31973599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis with intravenous tissue plasminogen activator predicts a favorable discharge disposition in patients with acute ischemic stroke.
    Ifejika-Jones NL; Harun N; Mohammed-Rajput NA; Noser EA; Grotta JC
    Stroke; 2011 Mar; 42(3):700-4. PubMed ID: 21293014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and effectiveness of low-dose recombinant tissue plasminogen activator (0.6 mg/kg) therapy for elderly acute ischemic stroke patients (≥ 80 years old) in the pre-endovascular era.
    Takayanagi S; Ochi T; Hanakita S; Suzuki Y; Maeda K
    Neurol Med Chir (Tokyo); 2014 Jun; 54(6):435-40. PubMed ID: 24670312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities and Trends in Door-to-Needle Time: The FL-PR CReSD Study (Florida-Puerto Rico Collaboration to Reduce Stroke Disparities).
    Oluwole SA; Wang K; Dong C; Ciliberti-Vargas MA; Gutierrez CM; Yi L; Romano JG; Perez E; Tyson BA; Ayodele M; Asdaghi N; Gardener H; Rose DZ; Garcia EJ; Zevallos JC; Foster D; Robichaux M; Waddy SP; Sacco RL; Rundek T;
    Stroke; 2017 Aug; 48(8):2192-2197. PubMed ID: 28706119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eligibility for Intravenous Recombinant Tissue-Type Plasminogen Activator Within a Population: The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial.
    de Los Ríos la Rosa F; Khoury J; Kissela BM; Flaherty ML; Alwell K; Moomaw CJ; Khatri P; Adeoye O; Woo D; Ferioli S; Kleindorfer DO
    Stroke; 2012 Jun; 43(6):1591-5. PubMed ID: 22442174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of Functional Outcomes in Patients with Stroke who Received Alteplase for Over 15 Years: Japan Stroke Data Bank.
    Ishigami A; Toyoda K; Nakai M; Yoshimura S; Wada S; Sasahara Y; Sonoda K; Miwa K; Koge J; Shiozawa M; Iwanaga Y; Miyamoto Y; Nakahara J; Suzuki N; Kobayashi S; Minematsu K; Koga M
    J Atheroscler Thromb; 2024 Jan; 31(1):90-99. PubMed ID: 37587045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between i.v. thrombolysis volume and door-to-needle times in acute ischemic stroke.
    Groot AE; van Schaik IN; Visser MC; Nederkoorn PJ; Limburg M; Aramideh M; de Beer F; Zwetsloot CP; Halkes P; de Kruijk J; Kruyt ND; van der Meulen W; Spaander F; van der Ree T; Kwa VI; Van den Berg-Vos RM; Roos YB; Coutinho JM
    J Neurol; 2016 Apr; 263(4):807-13. PubMed ID: 26946499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials.
    Gumbinger C; Reuter B; Stock C; Sauer T; Wiethölter H; Bruder I; Rode S; Kern R; Ringleb P; Hennerici MG; Hacke W;
    BMJ; 2014 May; 348():g3429. PubMed ID: 24879819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Local Tailoring on Acute Stroke Care in 21 Disparate Emergency Departments: A Prospective Stepped Wedge Type III Hybrid Effectiveness-Implementation Study.
    McKee KE; Knighton AJ; Veale K; Martinez J; McCann C; Anderson JW; Wolfe D; Blackburn R; McKasson M; Bardsley T; Ofori-Atta B; Greene TH; Hoesch R; Püttgen HA; Srivastava R
    Circ Cardiovasc Qual Outcomes; 2024 May; 17(5):e010477. PubMed ID: 38567507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of immediate thrombolytic treatment in imaging area on functional outcome in patients with acute ischemic stroke.
    De Mase A; Spina E; Servillo G; Barbato S; Leone G; Giordano F; Muto M; Guarnieri G; Alfieri G; Longo K; Di Iorio W; Muto M; Candelaresi P; Andreone V
    Neurol Sci; 2024 Apr; 45(4):1557-1563. PubMed ID: 37926747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous thrombolysis with rt-PA in stroke: experience of the moroccan stroke unit.
    Chtaou N; Rachdi L; Midaoui AE; Souirti Z; Wahlgren N; Belahsen MF
    Pan Afr Med J; 2016; 24():207. PubMed ID: 27795802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral autoregulation: A reliable predictor of prognosis in patients receiving intravenous thrombolysis.
    Guo ZN; Qu Y; Shen ZD; Liu J; Wang ZX; Sun YY; Zhang KJ; Chang J; Si XK; Jin H; Sun X; Yang Y
    CNS Neurosci Ther; 2024 May; 30(5):e14748. PubMed ID: 38727518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent Inequities in Intravenous Thrombolysis for Acute Ischemic Stroke in the United States: Results From the Nationwide Inpatient Sample.
    Sun P; Zheng L; Lin M; Cen S; Hammond G; Joynt Maddox KE; Kim-Tenser M; Sanossian N; Mack W; Towfighi A
    J Am Heart Assoc; 2024 May; 13(9):e033316. PubMed ID: 38639371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants of WNT7A and GPR124 are associated with hemorrhagic transformation following intravenous thrombolysis in ischemic stroke.
    Ta S; Rong X; Guo ZN; Jin H; Zhang P; Li F; Li Z; Lin L; Zheng C; Gu Q; Zhang Y; Liu W; Yang Y; Chang J
    CNS Neurosci Ther; 2021 Jan; 27(1):71-81. PubMed ID: 32991049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Day of the Week and Time of Arrival on Ischemic Stroke Management.
    Rodríguez-Rivera IV; Santiago F; Estapé ES; González-Sepúlveda L; Brau R
    P R Health Sci J; 2015 Sep; 34(3):164-9. PubMed ID: 26356742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strokes Averted by Intravenous Thrombolysis: A Secondary Analysis of a Prospective, Multicenter, Controlled Trial of Mobile Stroke Units.
    Navi BB; Bach I; Czap AL; Wang M; Yamal JM; Jacob AP; Parker SA; Rajan SS; Mir S; Sherman C; Willey JZ; Saver JL; Gonzalez MO; Singh N; Jones WJ; Ornelas D; Gonzales NR; Alexandrov AW; Alexandrov AV; Nour M; Spokoyny I; Mackey J; Collins SQ; Silnes K; Fink ME; English J; Barazangi N; Bratina PL; Volpi J; Rao CPV; Griffin L; Persse D; Grotta JC
    Ann Neurol; 2024 Feb; 95(2):347-361. PubMed ID: 37801480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in process management and in-hospital delays in treatment with iv thrombolysis.
    Ferrari J; Knoflach M; Seyfang L; Lang W;
    PLoS One; 2013; 8(9):e75378. PubMed ID: 24069406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary Angiography Complicated by Acute Ischaemic Stroke and the Use of Thrombolysis: a Cardiology Perspective and Narrative Review of Current Literature.
    Gin J; Yeoh J; Thijs V; Clark D; Ho JK; Horrigan M; Farouque O; Al-Fiadh A
    Curr Cardiol Rep; 2023 Nov; 25(11):1499-1512. PubMed ID: 37847358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supra-Blan
    Jin H; Peng Q; Li M; Sun S; Zhou J; Hu J; Huang M; Chen X; Li Y; Zhou Y; Wan Y; Hong C; Chen S; Hu B
    CNS Neurosci Ther; 2024 Feb; 30(2):e14381. PubMed ID: 37519114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.